“[Budget impact analysis of delayed-release dimethyl-fumarate in the treatment of relapsing-remitting multiple sclerosis in Italy]” (2016) Farmeconomia. Health economics and therapeutic pathways, 17(1), pp. 29–39. doi:10.7175/fe.v17i1.1237.